NG9:FRA
NeoGenomics, Inc.
€14.10
arrow_upward
+0.36%(+0.050) 1D
Oct 9, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NG9...
Open
€14.10
High
€14.10
Low
€14.10
Mkt. cap
2.10B
Avg. vol.
150.00
Volume
0.00
52-wk high
€17.26
52-wk low
€6.20
No. of employees
2K
Open
€14.10
High
€14.10
Low
€14.10
Mkt. cap
2.10B
Avg. vol.
150.00
Volume
0.00
52-wk high
€17.26
52-wk low
€6.20
No. of employees
2K
News stories
From web sources and news partners
The News-Press
·
3 days ago
NeoGenomics picks Warren Stone to lead company in Fort Myers
Profile
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
About NeoGenomics, Inc.
CEOChristopher M. Smith
Employees2.5K
Founded2002
HeadquartersFort Myers, Florida, United States
SectorHealth care provider
Websiteneogenomics.com